Search filters

List of works by Ana M. Bajo

Analysis of vasoactive intestinal peptide receptors and the G protein regulation of adenylyl cyclase in seminal vesicle membranes from streptozotocin-diabetic rats

scientific article published on 01 February 1994

Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer

scientific article published on 19 July 2016

Antioxidant activity of vasoactive intestinal peptide in HK2 human renal cells.

scientific article

Association of adenylate cyclase with an actin-like protein in the human myometrium.

scientific article

Biological evaluation of water soluble arene Ru(II) enantiomers with amino-oxime ligands

scientific article published on 06 March 2018

Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers.

scientific article published on January 2004

Does [-2]Pro-Prostate Specific Antigen Meet the Criteria to Justify Its Inclusion in the Clinical Decision-Making Process?

scientific article published on 18 January 2018

Effect of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats.

scholarly article

Effective treatment of experimental ES-2 human ovarian cancers with a cytotoxic analog of luteinizing hormone-releasing hormone AN-207.

scientific article published in October 2002

Expression of vasoactive intestinal peptide (VIP) receptors in human uterus

scientific article (publication date: September 2000)

Fibroblasts from the transversalis fascia of young patients with direct inguinal hernias show constitutive MMP-2 overexpression

scientific article published on 01 February 2001

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.

scientific article

Growth hormone-releasing hormone (GHRH) promotes metastatic phenotypes through EGFR/HER2 transactivation in prostate cancer cells

scientific article published on 10 February 2017

Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models.

scientific article

Growth hormone-releasing hormone induced transactivation of epidermal growth factor receptor in human triple-negative breast cancer cells

scientific article published on 2 November 2016

Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancer

scientific article published on 10 May 2018

Hydrogen bonding and anticancer properties of water-soluble chiral p-cymene Ru(II) compounds with amino-oxime ligands

scientific article (publication date: May 2015)

Impairment of adenylate cyclase activity and G-proteins in human uterine leiomyoma.

scientific article

Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide

scientific article published on 01 November 2001

Novel enantiopure cyclopentadienyl Ti(IV) oximato compounds as potential anticancer agents.

scientific article published on 09 December 2015

Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer.

scientific article published on 5 August 2010

Ontogeny of vasoactive intestinal peptide receptors in rat ventral prostate

scientific article published on 01 May 1994

RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells.

scientific article

Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN-215) and a bombesin antagonist (RC-3095).

scientific article published in October 2010

Signalling pathways involved in antitumoral effects of VIP in human renal cell carcinoma A498 cells: VIP induction of p53 expression.

scientific article

Solubilization of adenylyl cyclase from human myometrium in a alphas-coupled form.

scientific article published in August 2003

Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonists

scientific article published on 17 July 2019

Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides

scientific article published on 01 April 1993

VIP induces NF-κB1-nuclear localisation through different signalling pathways in human tumour and non-tumour prostate cells.

scientific article

VIP receptor/effector system in liver membranes from cholestatic rats

scientific article published on 01 January 1994

Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells.

scientific article published on 28 June 2007

Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1.

scientific article published on 14 August 2010

Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells.

scientific article

Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model.

scientific article published on 3 May 2007

Paulina is supported by:

About Paulina

Help